Corrigendum to the Annual Report for the Financial Year 2024-25
KOVAI · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Kovai Medical Center and Hospital Ltd has issued a corrigendum to its FY 2024-25 Annual Report, correcting a typographical error in Annexure-I of the Directors' Report on page 24. No other changes have been made to the report. The corrected version is available on the company's website. The Annual Report also covers the 39th AGM scheduled for August 22, 2025. Key business highlights for FY 2024-25 include revenue of Rs. 1,393 crore (12% growth, 13.96% CAGR over 7 years), EBITDA of Rs. 408 crore (19.37% CAGR), net worth of Rs. 1,086 crore (21.18% CAGR), and EPS of Rs. 190.95 (23.07% CAGR). The Board has recommended a 100% dividend. The company is planning a 300-400 bed hospital in Chennai and adding 100 beds at its main Coimbatore campus.
The corrigendum itself is minor and unlikely to impact the stock, but the AGM items are significant: a 100% dividend, borrowing approval of up to Rs. 2,500 crore, and re-appointment of Dr. Thavamani Devi Palaniswami as Joint Managing Director signal continued growth focus and shareholder rewards. Expansion plans into Chennai and new bed capacity could support future revenue growth.